VIMTA LABS  
                     | 
                    
                
The Current P/S Ratio of VIMTA LABS  is 9.03.
                
| Share Price | ₹682.2 | Nov 03,2025 | 
| Market Cap | ₹3,035.6 Cr | |
| Sales-TTM | ₹336.1 Cr | TTM-Consolidated Results | 
| Price/Sales | 9.03x | Calculated as Market Cap/Sales | 
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of VIMTA LABS
                    P/S = 
                    Market Capitalization  
                    /
                    Sales
                    
                    or, using per-share numbers:
                    
                    P/S = Stock Price / Sales Per Share
                
                Current Market Cap [ ₹3,035.6 Cr] as on Nov 03,2025                
                                    (/) Sales [ ₹336.1 Cr] based on TTM-Consolidated Results
                                    
                
                (=) P/S Ratio [ 9.03x ]
            
Thus, for VIMTA LABS , the investors are currently willing to pay '9.03 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of VIMTA LABS !
The chart below summarizes the trend in P/S Ratio of VIMTA LABS over the last five years.
Historical PS (Price/Sales) ratio chart of VIMTA LABS
PS Ratio Performance Analysis for VIMTA LABS
- VIMTA LABS 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 2.04x.
- VIMTA LABS 's operated at median p/e ratio of 2.19x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, VIMTA LABS 's p/e ratio peaked in Mar2024 at 3.1x.
- VIMTA LABS 's p/e ratio hit its five-year low in Mar2020 of 0.72x.
How does VIMTA LABS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) | 
|---|---|---|---|
| VIMTA LABS | 336.1 | 9.03 | 3,035.6 | 
| SUN PHARMACEUTICAL INDUSTRIES LTD | 53,777.1 | 7.62 | 409,626.0 | 
| DIVIS LABORATORIES LTD | 9,652.0 | 18.72 | 180,669.0 | 
| CIPLA LTD | 28,349.6 | 4.31 | 122,103.0 | 
| TORRENT PHARMACEUTICALS LTD | 11,835.0 | 10.38 | 122,793.0 | 
| DR REDDYS LABORATORIES LTD | 34,310.0 | 2.91 | 99,857.4 | 
| MANKIND PHARMA LTD | 12,956.2 | 7.65 | 99,138.4 | 
| ZYDUS LIFESCIENCES LTD | 23,607.7 | 4.18 | 98,686.4 | 
| LUPIN LTD | 23,375.9 | 3.88 | 90,706.1 | 
| AUROBINDO PHARMA LTD | 32,024.8 | 2.10 | 67,259.7 | 
| ABBOTT INDIA LTD | 6,589.9 | 9.38 | 61,800.2 | 
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs VIMTA LABS 's P/S Ratio
| Top 10 Industry Peers | PS Ratio | 
|---|---|
| Min industry PS | 2.10x | 
| Max industry PS | 18.72x | 
| Median industry PS | 7.62x | 
| Average industry PS | 7.29x | 
You may also like the below Video Courses